Nama Insights

Align Technology (ALGN)

Healthcare · Medical Instruments Supplies · NASDAQ

S&P 500
Align Technology (ALGN) is a Healthcare company in the Medical Instruments Supplies industry. It has a market capitalization of $11.26B, a trailing price-to-earnings ratio of 14.1 and a free-cash-flow yield of 4.2%. Over the most recent reported fiscal year, revenue grew 0.9% and free cash flow per share fell 18.6%. Nama's AI scorecard rates it Buy, 7.3 out of 10. On 12-month momentum it ranks in the middle band of its market.
AI scorecard
Buy · 7.3/10
Clearly positive, short of the top band. As of Nov 20, 2026.
Momentum
Middle · +14.0% over 12 months ex. last
Middle fifth of its market on the past year's move.
Shariah screen
Shariah Compliant
Passes our debt, cash and income screen; not a scholar's ruling.
Off its high
-77.5%
How far the last close sits under the highest price of the past five years.
Market cap$11.26B
Trailing P/E14.1
Price / book2.6
Price / sales2.7
FCF yield4.2%
Dividend yield—
Gross margin69.1%
Operating margin17.2%
Net margin11.8%
Revenue growth (YoY)+0.9%
Revenue growth (3-yr annual)+2.6%
EPS growth (YoY)+12.6%
FCF/share growth (YoY)-18.6%
Beta1.7
ExchangeNASDAQ
SectorHealthcare
IndustryMedical Instruments Supplies

ALGN earnings

Next report: Feb 3, 2027 (Q4 2026, EPS estimate $3.05). Beat the EPS estimate in 4 of 4 recent quarters.

QuarterReportedEPSEstimateSurpriseRevenue
Q3 2026 Oct 28, 2026 $2.80 $2.76 +1.4% $1.01B
Q2 2026 Jul 29, 2026 $2.64 $2.60 +1.5% $1.06B
Q1 2026 Apr 29, 2026 $2.58 $2.29 +12.7% $1.04B
Q4 2025 Feb 4, 2026 $3.29 $2.97 +10.8% $1.05B

ALGN analyst price target

Median target $190.50 from 14 analysts, ranging $160.00 – $210.00.

Medical Instruments Supplies peers

TickerCompanyMarket capP/E
ISRG Intuitive Surgical $141.17B 37.6
BDX Becton, Dickinson $57.93B 16.1
MDLN Medline $49.80B 23.9
ALC Alcon $35.79B 22.0
RMD ResMed $33.32B 20.5
WST West Pharmaceutical Services $27.63B 43.1
SOLV Solventum $14.58B 12.2
BAX Baxter International $13.14B 13.1
Explore live ALGN data on Nama Insights →

Recent Congressional trades

Align Technology trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member Chamber Trade Amount Disclosed
Lisa McClain House Sell $1,001 - $15,000 Oct 22, 2025
Lisa McClain House Buy $1,001 - $15,000 Sep 12, 2025
Rob Bresnahan House Sell $1,001 - $15,000 May 8, 2025
Rob Bresnahan House Buy $1,001 - $15,000 Mar 27, 2025
Gilbert Cisneros House Sell $1,001 - $15,000 Mar 6, 2025
Josh Gottheimer House Sell $1,001 - $15,000 Jun 8, 2024
Josh Gottheimer House Sell $1,001 - $15,000 Nov 11, 2023

ALGN FAQ

Is ALGN a buy?
Nama's AI scorecard currently rates Align Technology Buy (7.3 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is ALGN's P/E ratio?
Align Technology trades at a trailing price-to-earnings ratio of 14.1.
When does ALGN report earnings?
Align Technology's next scheduled report is on Feb 3, 2027. Analysts expect EPS of $3.05.
What is the ALGN price target?
The median analyst price target from 14 analysts is $190.50, with a range of $160.00 – $210.00.
Is ALGN Shariah compliant?
Nama's AAOIFI-style screen reads Align Technology as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.